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Abstract The aim of the study was the development and clinical 
application of patient selection algorithm for surgical treatment of long-
lasting persistent atrial fibrillation. The study included 235 patients with 
acquired heart disease and coronary artery disease, which in the period 
from 1999 to 2015 performed surgical treatment of long-term persistent 
atrial fibrillation (RF "MAZE III" procedure) in conjunction with the 
correction of the underlying heart disease. The patients were divided into 2 
groups according to the method of operation: the group 1 – 135 patients 
(76 women and 59 men) who have applied an integrated approach to 
surgery for atrial fibrillation, including penetrating method of RF effects 
on atrial myocardium and the study of the function of the sinus node before 
and after the operation (these patients were operated on from 2008 to 
2015). The group 2 – 100 patients (62 women and 38 men) with a 
"classical" method of monopolar RF "MAZE III", which the sinus node 
function was not studied. We used the combined (epi- and endocardial) 
method of RF «MAZE». This algorithm is decreasing of possible 
permanent pacemaker postoperatively. The initial sinus node function in 
these patients, measured using the original method, the basic line of this 
algorithm was taken. The results showed that use this algorithm for 
selection of patients allows significantly reduce the possibility of 
pacemaker implantation in the postoperative period. 
1 Introduction 
Improving the efficiency of radiofrequency (RF) ablation "MAZE III" due to sinus rhythm 
(grade 4 on a scale of Santa Crus) [1] is an actual problem in modern surgical 
arrhythmology. 
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The drug treatment of AF is usually ineffective and reduced to the control of ventricular 
rate and prevention of thromboembolic complications. Measures aimed at the preservation 
of sinus rhythm are effective only in paroxysmal AF when the main mechanism of its 
development is a trigger. When myocardial substrate for maintenance of AF is forming, and 
the micro re-entry is developing, drug therapy becomes ineffective [2–4]. Thus, the 
development of surgical treatment of persistent and prolonged persistent AF becomes 
especially over other methods. 
At the same time, the effectiveness of carefully performed radiofrequency procedure 
"MAZE III" in some cases significantly reduced due to postoperative sinus node 
dysfunction. Therefore, even a well-executed surgery does not lead to a significant 
improvement in patient well-being. In addition, these patients are in need of long-term 
temporary pacing and prolonged presence in the intensive care unit, and in some cases they 
need the pacemaker implantation. 
In a number of scientific papers was shown [3–8], that the long persistent AF reduces 
the likelihood of recovery of sinus rhythm after the procedure, "MAZE III", however, does 
not provide a method to estimate the initial functional state of the sinus node during AF. 
Atrial fibrillation makes excessive load on atrial cardiomyocytes, during episodes of atrial 
fibrillation. This leads to the activation of neurohumoral mechanisms (mainly cardiac 
angiotensin II), which trigger mechanism "structural remodeling", leading to dilatation, 
hypertrophy, structural disorganization of myofibrils fibrosis and atrial myocardium, that 
escalate the processes of "electrical remodeling" and supports AF [4, 9, 10]. Thus, atrial 
fibrillation itself maintains and exacerbates the atrial fibrillation, leading to cell 
degeneration of sinoatrial node. 
Thus, the preservation of the sinoatrial node function in patients during atrial 
radiofrequency fragmentation scheme "MAZE III" is one of the leading problems. 
In the literature, forecasting methods the recovery of sinoatrial node function after 
surgical treatment of AF with cardiopulmonary bypass has not been found. The close 
similar is a method for predicting the successful restoration of sinus rhythm after the 
procedure, "MAZE III", associated with the preoperative analysis of electrocardiograms 
and standard chest leads [3, 11, 12]. The method is a f-wave analysis on the 
electrocardiogram. Restoration of normal sinus rhythm is possible if the amplitude of the f-
waves of more than 0.1 mV. 
The method disadvantage is it does not provide direct information about the 
preoperative electrophysiological condition of sinoatrial node. This one allows to predict 
only the restoration of normal atrial contractile activity. It cannot give a reliable forecast for 
the restoration of normal sinoatrial node function after the procedure, "MAZE III". In 
addition, an important disadvantage is the fact that there is no clear algorithm for the 
selection of patients for atrial radiofrequency fragmentation scheme "MAZE III", is based 
on the prevention of sinoatrial node dysfunction. 
The aim of study is prognosis normal sinus rhythm recovery RF procedure "MAZE III", 
performed with cardiopulmonary bypass. 
2 Materials and methods 
The study included 235 patients with acquired heart disease and coronary artery disease, 
which in the period from 1999 to 2016 performed surgical treatment of long-term persistent 
atrial fibrillation (RF "MAZE III" procedure) in conjunction with the correction of the 
underlying heart disease. The patients were divided into 2 groups according to the method 
of influence: the first (primary) group –135 patients (76 women and 59 men) who have 
applied an integrated approach to surgery for atrial fibrillation, including penetrating 











before and after the surgery (these patients were operated on from 2008 to 2015). The 
second group – 100 patients (62 women and 38 men) with a "classical" method of 
monopolar RF "MAZE III", which the sinus node function was not studied (operated from 
1999 to 2008.) [13]. We used the combined (epi- and endocardial) method of RF «MAZE» 
in both groups. Clinical characteristics and operations by groups are shown in Table  
(Table 1). 
All patients before surgery were classified as II–III functional class (FC) according to 
the classification of New-York Heart Association (NYHA). Heart diseases were diagnosed 
on the basis of anamnesis, results of physical and instrumental studies. All patients 
underwent preoperative echocardioscopy with the definition of the morphology of valvular 
lesions and the degree of hemodynamic transvalvular blood flow (gradient, valve orifice 
area, effective area and regurgitant volume, the ratio of the effective area of the valve 
opening in the patient's body surface area). The etiology of heart diseases and 
hemodynamic types listed in the table (Table 1). Both groups of patients are identical, the 
differences between them in terms of preoperative statistically insignificant. Beta-blockers 
received 221 patients (94%), angiotensin converting enzyme (ACE) inhibitors and diuretics 
obtained all patients (Table 2). Some patients received prehospital digoxin and amiodarone. 
5 days prior to surgery patients were canceled beta-blockers, amiodarone and digoxin. 
According to the test with a 6-minute walk 221 patient was classified to III functional class 
(FC) of heart failure (according to NYHA), 14 patients – to the class II of NYHA. Also, all 
patients recorded 12-lead ECG, according to testimony – Daily Holter ECG monitoring. All 
patients older than 40 years (men) and 45 years (women) before surgery performed 
coronary angiography. Sampling solid, inclusion criteria for patients were the presence long 
persistent atrial fibrillation, resistance to drug therapy, combined heart defects requiring 
surgical correction. Exclusion criteria were the presence of severe comorbidities, multiple 
organ dysfunction syndrome, intolerance of iodine preparations, patient reluctance to 
participate in the study. 
In the first group, all patients underwent electrophysiological study (EPS) of the 
sinoatrial node function by proposed technology. We used diagnostic complex "Elcart-M" 
("Electropulse", Tomsk). Electrophysiological study protocol included a portion of the right 
atrium stimulation in order to assess the automatic function of the sinoatrial node (the 
definition of recovery time of sinoatrial node function and correct recovery time of 
sinoatrial node function) and becomes overdrive stimulation of the right atrium to the 
development of AV block grade 2 ("Wenckebach point"). Electrophysiological study of 
preoperative sinoatrial node function performed intraoperatively before the heart structure 
separation and beginning of cardiopulmonary bypass. This was done to minimize the 
external impact on the sinoatrial node tissue. The study was carried out as follows: 
intraoperative transesophageal performed ultrasound of the heart and in the absence of 
thrombosis of heart cavities cardioversion was performed. In the case of sinus rhythm after 
10 minutes was performed electrophysiological study of the function of the sinoatrial node. 
According to the results of preoperative EPS Group 1 patients were divided into 2 
subgroups: Subroup 1 with normal sinus automatism (118 patients); Subroup 2 with signs 
of sinoatrial node dysfunction (17 patients). After the main phase of the operation and 
remove the cannula lung machine from the cavities of the heart and great vessels, in case of 

















Table 1. Clinical characteristics of patients. 
 Group 1 Group 2 
The total number of patients, n 135 100 
Male / female ratio 0.78 0.61 
Mean age, years of 53.5±8.8 50.8±9.8 
FC (NYHA) 2.3±1.1 2.4±0.9 
The right atrium diameter, mm 62.5±5.7 63.2±7.9 
The left atrium diameter, mm  50.3±6.12 53.2±7.9 
The left atrium volume, ml 225.1±3.6 223.4±4.8 
Pulmonary artery systolic pressure, 
mmHg 
48.5±3.6 49.6±10.4 
The mean lasting of AF, years 4.3±2.4 4.6±3.1 
Diseases which are complicated by AF 
Congenital heart diseases 10 14 
acquired heart diseases 112 83 
Ischemic heart disease 8 3 
The etiology of heart diseases 
Rheumatism 74 71 
Degenerative aortic valve calcification 3 1 
Connective tissue dysplasia 36 7 
Congenital septal defect 10 16 
Dilated cardiomyopathy 4 2 
Operations 
Mitral valve replacement 42 35 
MV replacement and tricuspid valve 
reconstruction 
15 34 
Mitral and aortic valves replacement 10 3 
Mitral and aortic valves replacement, 
tricuspid valve reconstruction 
- 3 
Mitral valve reconstruction 48 4 
Aortic valve replacement 2 1 
ASD closing 10 16 
ASD closing+CABG - 1 
CABG 4 3 
Mitral valve replacement+CABG 4 - 
Left atrioplasty 28 11 
 
Statistical processing of the data was performed using the software package SPSS 15.0 
for Windows (SPSS Software Products). Compliance testing samples of normal distribution 
was performed Shapiro-Wilk test criterion (Shapiro-Wilk). Description of data was carried 
out using mean and standard deviation – M ± StD. The Student's t-test was used for assess 
the reliability of inter-group differences. Paired Student's t-test was used for assess the 
reliability of intragroup differences (dynamics of indicators pre-surgery within one group). 
The significance level "p" was taken to be 0.05, respectively, the confidence  
level (p) = 0.95. 
Table 2. Drug therapy before surgery. 
The group of drugs Group 1 (n, %) Group 2 (n, %) 
Beta-blockers 129 (90,6%) 92 (92%) 
ACE inhibitors 135 (100%) 99 (99%) 
Diuretics 135 (100%) 100 (100%) 
Digoxin 22 (16 %) 31 (31%) 












As a result of the study, patients in Group 1 in the Subgroup 1 mean recovery time of 
sinoatrial node function and correct recovery time of sinoatrial node function initially was 
1033.7 ± 101.2 ms and 242.3 ± 40.1 ms respectively. All patients of Subgroup 1 had 
postoperative sufficient rate sinus rhythm. During the EPS after the intervention, the mean 
recovery time of sinoatrial node function and correct recovery time of sinoatrial node 
function in this subgroup was 1020.3 ± 203.1 ms and 305 ± 60.4 ms, respectively (Figure 1, 
2). 
 
Figure 1. Patient’s electrograms (subgroup 1) before surgery: 
1) the original electrogram; I, II, III – standard leads; 2) the electrogram after cardioversion and sinus 
rhythm; I, II, III – standard leads; E5 – the sinoatrial node electrogram; 3) frequent stimulation of the 
right atrium in order to assess the automatic function of the sinoatrial node (recovery time of 
sinoatrial node function); I, II, III – standard leads; E5 – the sinoatrial node electrogram. 
 
 
Figure 2. Patient’s electrograms (subgroup 1) before surgery: 
1)the original electrogram; I, II, III – standard leads; 2) frequent stimulation of the right atrium in 
order to assess the automatic function of the sinoatrial node (recovery time of sinoatrial node 
function); I, II, III – standard leads; E5 – the sinoatrial node electrogram. 
 
 
Figure 3. Patient’s electrograms (subgroup 1) before surgery: 
1) the original electrogram; I, II, III – standard leads; 2) the electrogram after cardioversion and sinus 
rhythm; I, II, III - standard leads; E5 – the sinoatrial node electrogram; 3) requent stimulation of the 
right atrium in order to assess the automatic function of the sinoatrial node (recovery time of 












The recovery time of sinoatrial node function and correct recovery time of sinoatrial 
node function in patients of subgroup 2 initially had mean of 1995 ± 30.1 ms and 971.5 ± 
102.4 ms, respectively (Figure 3). 
In this subgroup of patients after surgery was observed sinoatrial node dysfunction and 
required temporary pacing mode AAI in up to 14 days (Figure 4). In 12 (71%) patients in 
the Subgroup 2 for the early postoperative period AF returned. 5 (29%) patients in this 
subgroup had pacemaker implantation. Thus, the total number of patients with irreversible 
sinoatrial node dysfunction was 17 people (12% of the patients of the group) (0 – 1 grading 
scale Santa Crus [1]). 
 
 
Figure 4. The electrogram of the patient from subgroup 2 after surgery; I, II, III – standard leads;  
E5 – the sinoatrial node electrogram (no activity). 
 
Patients of Subgroup 1 did not require a temporary pacemaker, on average, more than 
3.4±2.1 days. All of them had sinus rhythm sufficient rate. 
Patients in group 2 had a significantly higher percentage of ineffective treatments 
"MAZE III", which consists in returning the AF and the need for pacemaker implantation 
(p<0.05) (Table 3). 
Table 3. Early and long-term results by groups. 




Subgroup 1 Subgroup 2 
Sinoatrial node dysfunction 
(in terms of up to 3.4 ± 2.1 
days) 
56 (47%) 
(41% of the total 
number of patients 
in the group) 
17 (100%) (12% of the 
total number of 
patients in the group) 
86 (86%) 
Sinoatrial node dysfunction 
(in terms of > 14 days) 
0 13 (76%) 
(9.6% of the total 
number of patients in 
the group) 
22 (22 %) 
ECMO 3 (2.2%) - 
Mortality 2 (1.5%) 2 (2%) 












In all patients, treatment of AF which has been found to be effective, there remains an 
active systole left and right atrium (A wave amplitude greater than 0.8 m/s). The A-wave is 
either absent or its amplitude <0.5 m/s in patients with sinoatrial node dysfunction. 
4 Discussion of the results 
Development of sinoatrial node dysfunction in patients with long-standing persistent atrial 
fibrillation is one of the reasons for the ineffectiveness of surgical treatment. This 
complication is not life-threatening in itself, but requires a long-term presence of the patient 
in intensive care, time spent pacing for a long time, and in some cases, the implantation of a 
permanent pacemaker [8, 14]. The sinoatrial node dysfunction develops as a result 
described by many researchers expressed the defeat of the host tissue and arteries, and its 
supply perinodal structures [5, 6, 15–17]. As pointed out by a number of researchers, 
sinoatrial node dysfunction provoked chronic AF, which in most cases is in these patients 
lengthening the time intraatrial and shortening of atrial refractoriness [3]. 
Possible causes of the sinoatrial node dysfunction after radiofrequency "MAZE" to 
"open" the heart are: 
1. The mechanical damage of the sinoatrial node arteries during access to the mitral valve. 
2. The thermal damage to the sinoatrial node during radiofrequency exposure on the 
myocardium. 
3. The initial sinoatrial node dysfunction. 
The first reason can be solved choice the atriotomy to the mitral valve [18, 19]. When 
selecting the atriotomy approach to the mitral valve is necessary to consider the type of 
myocardial perfusion. In all cases, preferred the left atriotomy approach is not leading to 
damage of the arteries supplying the sinus node, but it is in some cases (at small sizes of left 
atria) provides visualization of mitral valve worse than the Guiraudon approach. When 
there is the right or balanced types of heart circulation, superior approach by Guiraudon is 
preferred. The transseptal approach to the mitral valve through right atria leads to damage 
of the arteries feeding the components of the conduction system in 100% cases [19]. 
To prevent thermal and wave damage to the sinus node is proposed and applied in clinic 
technique penetrating effects on atrial myocardium. Features of this method lies in the fact 
that the original design of the monopolar electrode allows for more effective impact on the 
transmural atrial myocardium in a shorter period of time, which reduces the area of damage 
and prevents involvement in the zone of influence elements of the conduction system of the 
heart [20]. 
A) Sinus rhythm without 
antiarrhythmic drugs 
120 (88%) 51 (51%) 
B) Sinus rhythm with 
antiarrhythmic drugs 
126 (93%) 68 (68%) 
Pacemaker  5 (3.7%) 10 (10%) 


















However, to evaluate the functional state of the sinus before surgery during the phase 
transition was not possible. The literature found messages on technology research sinoatrial 
node functions in patients with long-term persistent AF. To solve this problem, we 
developed an original method of intraoperative evaluation sinoatrial node functions in these 
patients. It allows electrophysiological study with the definition of recovery time of 
sinoatrial node, correct the recovery time of sinus node function and "Wenckebach point" 
(becoming more frequent stimulation of the right atrium to the development of AV block 
degree 2). 
Evaluation of sinoatrial node function using the technology developed before the 
procedure "MAZE III", correlates with its function in the late postoperative periods. Thus, 
the proposed technology allows to evaluate the function of the sinus node and conduction 
system of the heart in patients with long-standing persistent AF. 
The findings suggest that while initially the compromised function of the sinoatrial node 
should not be expected in the postoperative effects of surgical treatment of AF in these 
patients. Moreover, given the initial severity of the condition of these patients, in some 
cases is unreasonable increase in the time of cardiopulmonary bypass to prevent 
complications, such as haemolysis, air embolism and systemic inflammatory response. 
Thus, to determine the indications for the procedure of "MAZE III" expedient to EPS on 
technology developed before the intervention with the assessment of the functional state of 
the sinoatrial node. When it is appropriate we need to assess the initial severity of the 
patient's condition and the effect on it of atrial fibrillation [21–25]. If AF has no 
pronounced negative effect on the hemodynamics of the patient, it makes sense to restrict 
the atrial appendages off by their resection and suturing, in addition to the main stage of the 
operation to reduce the risk of thromboembolic complications. 
Thus, based on the above-described method for evaluating the function of sinus node 
selection algorithm can provide patients with long persistent AF for surgical treatment. 
5 Conclusion 
The proposed method for evaluating sinus node function in patients with long-standing 
persistent atrial fibrillation can be used to predict the successful restoration of sinus rhythm 
after the procedure, "MAZE III". A set of activities aimed at preserving the function of the 
sinus node, is able to increase the effectiveness of surgical treatment of atrial fibrillation. If 
there is the original sinus node dysfunction in patients, the surgical treatment of long-term 
persistent AF is not very promising in terms of the sinus rhythm restoration. 
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